Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Ag tech startup Farmobile raises $18M round for global expansion
Ag tech company Farmobile has reaped a substantial Series B funding round that positions the firm to rapidly accelerate across the world. The Overland Park-based company announced Friday that it raised $18.1 million to expand its data platform to help farmers mitigate risks and generate a revenue from the data they own. The round includes…
10-year-old Leawood inventor in the running for $250K
Kansas City entrepreneurs are known for their Midwestern hospitality, collaborative nature and humility. And each of those traits are expressed by 10-year-old inventor Julia Luetje of Leawood, whose entrepreneurial spirit is now on the national stage as part of a Frito-Lay’s Dreamvention competition. “I invented the Storm Sleeper because I used to be afraid of…
Face it: Zoloz tech lets you to pay with a smile
With a recently revealed new brand and broader strategic focus, Kansas City-based Zoloz is expanding its biometrics security offerings to include another unique human attribute: a user’s face. Formerly known as EyeVerify, Zoloz unveiled three new products — Zoloz Connect, Real ID and Smile — that CEO Toby Rush said will ensure trust and security…
Minddrive fuels youth development through hands-on STEM
Carlos Alonzo, a 15-year-old engineer at Minddrive, was always good at math. In the seventh grade, Alonzo’s teachers gave him the opportunity to skip ahead and take algebra. Although he enjoyed it and did well in the class, he ran into a problem: His school didn’t offer him an advanced class for eighth grade. That one-year…